InvaGen Pharmaceuticals, Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 7 Oser Ave., Hauppauge, New York (NY) 11788, United States (USA)
- Operations here
- analysislabelmanufacturepackrepack
- FDA identifiers
- FEI 3003950641 · DUNS 165104469
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-10-25
- VAIDrug Quality Assurance2019-12-06
- VAIDrug Quality Assurance2018-05-25
- VAIDrug Quality Assurance2017-03-30
- NAIBioresearch Monitoring2016-04-20
- VAIDrug Quality Assurance2015-05-26
- VAIBioresearch Monitoring2015-03-13
- VAIDrug Quality Assurance2015-03-13
- VAIDrug Quality Assurance2013-03-08
- VAIDrug Quality Assurance2012-06-14
- VAIDrug Quality Assurance2012-03-02
- NAIBioresearch Monitoring2011-08-12
- VAIDrug Quality Assurance2011-04-13
- VAIDrug Quality Assurance2010-11-10
- VAIDrug Quality Assurance2010-08-27
- VAIDrug Quality Assurance2010-02-19
- VAIBioresearch Monitoring2009-05-12
- VAIDrug Quality Assurance2009-05-12
Drugs this plant is listed as making
52 distinct drugs across 183 products name this site in their FDA label.
- Alfuzosin hydrochlorideExelan Pharmaceuticals Inc.
- Amlodipine besylateExelan Pharmaceuticals, Inc.
- BenztropineCipla USA Inc.
- Bupropion HydrochlorideCipla USA Inc.,
- Calcium AcetateExelan Pharmaceuticals, Inc.
- CitalopramExelan Pharmaceuticals Inc.
- CyclobenzaprineExelan Pharmaceuticals, Inc.
- EscitalopramCipla USA Inc.
- fenofibrateCipla USA Inc.,
- FinasterideExelan Pharmaceuticals Inc.
- FosinoprilCipla USA Inc.
- Fosinopril sodiumExelan Pharmaceuticals, Inc.
- Fosinopril Sodium and HydrochlorothiazideCipla Usa Inc.
- GabapentinCipla USA Inc.
- GemfibrozilCipla USA Inc.
- HydrALAZINE HydrochlorideExelan Pharmaceuticals Inc.
- Lanthanum CarbonateCipla USA Inc.
- LevetiracetamExelan Pharmaceuticals, Inc.
- lisinoprilExelan Pharmaceuticals Inc.
- Lisinopril and Hydrochlorothiazide TabletsCipla USA Inc.
- Lurasidone HydrochlorideExelan Pharmaceuticals Inc.
- NabumetoneCipla USA Inc.
- NadololBluePoint Laboratories
- naproxenCipla USA Inc.
- PregabalinExelan Pharmaceuticals Inc.
- Quinaprilin shortageCipla USA Inc.
- quinapril and Hydrochlorothiazide 10/12.5Cipla USA Inc.
- Quinapril and Hydrochlorothiazide 20/12.5Cipla USA Inc.
- Quinapril and Hydrochlorothiazide 20/25Cipla USA Inc.
- RaloxifeneCipla USA Inc.
- Raloxifene HydrochlorideExelan Pharmaceuticals, Inc.
- Rizatriptan BenzoateCipla USA Inc.
- SertralineExelan Pharmaceuticals, Inc.
- Sevelamer CarbonateCipla USA Inc.
- TerbinafineExelan Pharmaceuticals Inc.
- TopiramateCipla USA Inc.
- Trospium ChlorideCipla Usa Inc.,
- vigabatrinCipla USA, Inc.
- Vilazodone hydrochlorideExelan Pharmaceuticals Inc.
- WarfarinExelan Pharmaceuticals Inc.
- ZolmitriptanCipla USA Inc.
- ZonisamideExelan Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.